Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Fimbrion Therapeutics, Inc. operates a life sciences firm. It discovers, develops, and commercializes antimicrobial-sparing, an antivirulence drugs for the prevention and treatment of infectious diseases caused by bacterias. The company was founded by Thomas M. Hooton, James W. Janetka, and Scott J. Hultgren in 2012 and is headquartered in St. Louis, MO.

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.

Forge Therapeutics, Inc is a biotechnology company discovering and developing novel therapeutics using an innovative chemistry platform targeting metalloproteins. Forge uses a proprietary approach combining bioinorganic (study of metals in biology) and medicinal chemistry to generate selective inhibitors of this large class of targets.

Ferring BV offers pharmaceutical products. It offers medicines in Gynaecology, Gastroenterology, Endocrinology and Urology. The company was founded in 1984 and is headquartered in Hoofddorp, Netherlands.

Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom.

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens. The company’s internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.

Blacksmith Medicines, Inc. is an American company located in San Diego, CA, with domestic subsidiaries. The firm develops medicines targeting metal-dependent enzymes found in human physiology. It was founded by Zachary A. Zimmerman, who is currently the CEO of the company.\nThe company says this about itself: At Blacksmith Medicines, we are developing medicines targeting metal-dependent enzymes. Over 30% of known enzymes are metalloenzymes, covering all major enzyme classes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases. Metal ions, including magnesium, zinc, iron, manganese and copper, are the essential ingredient in these metalloenzymes. We recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes.

President & CEO

Zhuzhou Qianjin Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. Its business activities include Chinese medicine, chemical medicine, and health supplies businesses. It produces medicines in the form of tablets, granules, and hard capsules. Its products are used for treatment of gynecological and obstetric, pediatric, circulatory, endocrine, digestive system, nervous system, and cardiovascular diseases. The company was founded in 1966 and is headquartered in Zhuzhou, China.

Synesis Group is a private IT firm and business incubator headquartered in Minsk, Belarus. Founded in 2007 as a software design powerhouse, Synesis helped Viber, Playtika, Yandex, Alfresco, and other well-known companies to develop successful products. Today, more than a billion people worldwide are using these products daily. As of today, Synesis has evolved into a service provider operating large projects for governments and global consumers. With a team of 1200+ world-class engineers, extensive product portfolio, and strong patent position, Synesis is one of the leading companies in Artificial Intelligence (AI).

Helperby Therapeutics (Helperby) is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics. Existing antibiotic treatments are rapidly becoming obsolete. Doctors increasingly rely on last resort antibiotics such as carbapenems and colistin. As harmful bacteria continue to mutate, this final line of resistance will eventually fail. Helperby’s unique antibiotic technology outsmarts highly resistant bacteria by combining new resistance breakers with old antibiotics to create a whole new generation of therapies. This new lease of life for antibiotics will help to sustain our defence against life threatening superbugs for years to come.

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

TCM Biotech International Corp. engages in the research, development, manufacturing and sale of medicines, medical devices and functional food. Its products include medicines for osteoporosis, iron drops, antiviral tablets, urinary system treatment tablets, urosan capsules, expectorant, antineoplastics agents, anti-hypertensive tablets, spironolactone tablets, anti-diabetic tablets, uformin tablets, glusafe tablets and medical equipment. The company was founded on February 20, 1998 and is headquartered in New Taipei, Taiwan.

Sequoia Vaccines, Inc. provides vaccine for recurrent urinary tract infections. Its vaccine treats female urinary-tract infections that keep recurring despite antibiotic therapy. The firm serves the medical industry. The company is headquartered in St. Louis, MO.

Merck Sharp & Dohme LLC, part of Merck & Co., Inc., is a company headquartered in Kenilworth, NJ, that operates as a pharmaceutical company.